472
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Misuse of prescription drugs and overdose deaths

, , , , &
Pages 515-520 | Received 26 Mar 2015, Accepted 23 Jul 2015, Published online: 24 Mar 2016

References

  • Ballesteros, M. F., Budnitz, D. S., Sanford, C. P., Gilchrist, J., Agyekum, G. A., & Butts, J. (2003). Increase in deaths due to methadone in North Carolina. JAMA, 290(1), 40. doi:10.1001/jama.290.1.40.
  • Bohnert, A. S., Valenstein, M., Bair, M. J., Ganoczy, D., McCarthy, J. F., Ilgen, M. A., & Blow, F. C. (2011). Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA, 305(13), 1315–1321. doi:10.1001/jama.2011.370.
  • Bramness, J. G., Furu, K., Engeland, A., & Skurtveit, S. (2007). Carisoprodol use and abuse in Norway: A pharmacoepidemiological study. British Journal of Clinical Pharmacology, 64(2), 210–218. doi:10.1111/j.1365-2125.2007.02847.x.
  • el-Guebaly, N., Sareen, J., & Stein, M. B. (2010). Are there guidelines for the responsible prescription of benzodiazepines? Canadian Journal of Psychiatry, 55(11), 709–714.
  • European Monitoring Centre for Drug and Drug Addiction (EMCDDA). (2009). Drug-Related Deaths and Mortality (DRD). Lisbon, Portugal: EMCDDA.
  • Fischer, B., Jones, W., Urbanoski, K., Skinner, R., & Rehm, J. (2013). Correlations between prescription opioid analgesic dispensing levels and related mortality and morbidity in Ontario, Canada, 2005–2011. Drug and Alcohol Review. doi:10.1111/dar.12089.
  • Fisher, J., Sanyal, C., Frail, D., & Sketris, I. (2012). The intended and unintended consequences of benzodiazepine monitoring programmes: A review of the literature. Journal of Clinical Pharmacy and Therapeutics, 37(1), 7–21. doi:10.1111/j.1365-2710.2011.01245.x.
  • Fredheim, O. M., Borchgrevink, P. C., Mahic, M., & Skurtveit, S. (2013). A pharmacoepidemiological cohort study of subjects starting strong opioids for nonmalignant pain: A study from the Norwegian Prescription Database. Pain. doi:10.1016/j.pain.2013.07.033.
  • Fredheim, O. M., Skurtveit, S., Breivik, H., & Borchgrevink, P. C. (2010). Increasing use of opioids from 2004 to 2007—Pharmacoepidemiological data from a complete national prescription database in Norway. European Journal of Pain, 14(3), 289–294. doi:10.1016/j.ejpain.2009.05.006.
  • Furu, K. (2008). Establishment of the nationwide Norwegian Prescription Database (NorPD)—New opportunities for research in pharmacoepidemiology in Norway. Norway Journal of Epidemiology, 18(2), 129–136.
  • Gilson, A. M., Ryan, K. M., Joranson, D. E., & Dahl, J. L. (2004). A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997–2002. Journal of Pain and Symptom Management, 28(2), 176–188. doi:10.1016/j.jpainsymman.2004.01.003.
  • Gjersing, L., Jonassen, K. V., Biong, S., Ravndal, E., Waal, H., Bramness, J. G., & Clausen, T. (2013). Diversity in causes and characteristics of drug-induced deaths in an urban setting. Scandinavian Journal of Public Health, 41(2), 119–125. doi:10.1177/1403494812472007.
  • Gossop, M., Stewart, D., Treacy, S., & Marsden, J. (2002). A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Addiction, 97(1), 39–47.
  • Hall, A. J., Logan, J. E., Toblin, R. L., Kaplan, J. A., Kraner, J. C., Bixler, D., … Paulozzi, L. J. (2008). Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA, 300(22), 2613–2620. doi:10.1001/jama.2008.802
  • Hausken, A. M., Furu, K., Skurtveit, S., Engeland, A., & Bramness, J. G. (2009). Starting insomnia treatment: The use of benzodiazepines versus z-hypnotics. A prescription database study of predictors. European Journal of Clinical Pharmacology, 65(3), 295–301. doi:10.1007/s00228-008-0565-8.
  • Havnes, I. A., Clausen, T., & Middelthon, A. L. (2013). “Diversion” of methadone or buprenorphine: “harm” versus “helping”. Harm Reduction Journal, 10(1), 24. doi:10.1186/1477-7517-10-24.
  • Ibanez, G. E., Levi-Minzi, M. A., Rigg, K. K., & Mooss, A. D. (2013). Diversion of benzodiazepines through healthcare sources. Journal of Psychoactive Drugs, 45(1), 48–56. doi:10.1080/02791072.2013.764232.
  • Inciardi, J. A., Surratt, H. L., Cicero, T. J., & Beard, R. A. (2009). Prescription opioid abuse and diversion in an urban community: The results of an ultrarapid assessment. Pain Medicine, 10(3), 537–548. doi:10.1111/j.1526-4637.2009.00603.x.
  • Inciardi, J. A., Surratt, H. L., Kurtz, S. P., & Cicero, T. J. (2007). Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. Pain Medicine, 8(2), 171–183. doi:10.1111/j.1526-4637.2006.00255.x.
  • Jamison, R. N., Serraillier, J., & Michna, E. (2011). Assessment and treatment of abuse risk in opioid prescribing for chronic pain. Pain Research and Treatment, 2011, 941808. doi:10.1155/2011/941808.
  • Jones, J. D., Mogali, S., & Comer, S. D. (2012). Polydrug abuse: A review of opioid and benzodiazepine combination use. Drug and Alcohol Dependence, 125(1–2), 8–18. doi:10.1016/j.drugalcdep.2012.07.004.
  • Modarai, F., Mack, K., Hicks, P., Benoit, S., Park, S., Jones, C., … Paulozzi, L. (2013). Relationship of opioid prescription sales and overdoses, North Carolina. Drug and Alcohol Dependence, 132(1–2), 81–86. doi:10.1016/j.drugalcdep.2013.01.006.
  • Paulozzi, L. J., Kilbourne, E. M., Shah, N. G., Nolte, K. B., Desai, H. A., Landen, M. G., … Loring, L. D. (2012). A history of being prescribed controlled substances and risk of drug overdose death. Pain Medicine, 13(1), 87–95. doi:10.1111/j.1526-4637.2011.01260.x.
  • Pauly, V., Pradel, V., Pourcel, L., Nordmann, S., Frauger, E., Lapeyre-Mestre, M., … Thirion, X. (2012). Estimated magnitude of diversion and abuse of opioids relative to benzodiazepines in France. Drug and Alcohol Dependence, 126(1–2), 13–20. doi:10.1016/j.drugalcdep.2012.03.009.
  • Peirce, G. L., Smith, M. J., Abate, M. A., & Halverson, J. (2012). Doctor and pharmacy shopping for controlled substances. Medical Care, 50(6), 494–500. doi:10.1097/MLR.0b013e31824ebd81.
  • Riggs, P. (2008). Non-medical use and abuse of commonly prescribed medications. Current Medical Research and Opinion, 24(3), 869–877. doi:10.1185/030079908x273435.
  • Skurtveit, S., Furu, K., Bramness, J., Selmer, R., & Tverdal, A. (2010). Benzodiazepines predict use of opioids—A follow-up study of 17,074 men and women. Pain Medicine, 11(6), 805–814. doi:10.1111/j.1526-4637.2010.00870.x.
  • Statistics Norway. (2015). Population and Quarterly Changes, Q4 2014. Retrieved March 24, 2015 from https://www.ssb.no/en/befolkning/statistikker/folkendrkv/kvartal/2015-02-19.
  • United Nations Office on Drugs and Crime (UNODC). (2011). The Non-Medical Use of Prescription Drugs: United Nations Office on Drugs and Crime.
  • Vijayaraghavan, M., Freitas, D., Bangsberg, D. R., Miaskowski, C., & Kushel, M. B. (2014). Non-medical use of non-opioid psychotherapeutic medications in a community-based cohort of HIV-infected indigent adults. Drug and Alcohol Dependence, 143, 263–267. doi:10.1016/j.drugalcdep.2014.06.044.
  • Walley, A. Y., Xuan, Z., Hackman, H. H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., … Ozonoff, A. (2013). Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: Interrupted time series analysis. BMJ, 346, f174. doi:10.1136/bmj.f174.
  • WHO Collaborating Centre for Drug Statistics Methodology. (2007). Guidelines for ATC Classification and DDD Assignment. Oslo, Norway: Norwegian Institute of Public Health.
  • Wilsey, B. L., Fishman, S. M., Gilson, A. M., Casamalhuapa, C., Baxi, H., Zhang, H., & Li, C. S. (2010). Profiling multiple provider prescribing of opioids, benzodiazepines, stimulants, and anorectics. Drug and Alcohol Dependence, 112(1–2), 99–106. doi:10.1016/j.drugalcdep.2010.05.007.
  • Yu, H. Y. (2012). The prescription drug abuse epidemic. Clinics in Laboratory Medicine, 32(3), 361–377. doi:10.1016/j.cll.2012.06.006.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.